Defence Therapeutics Inc.
DTC
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.59M | -2.52M | -2.67M | -2.99M | -8.53M |
| Total Depreciation and Amortization | 50.70K | 51.90K | 73.50K | 77.90K | 70.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 744.60K | 739.10K | 672.40K | 499.30K | 4.64M |
| Change in Net Operating Assets | -1.20M | -669.70K | -270.40K | 912.70K | 1.77M |
| Cash from Operations | -2.99M | -2.40M | -2.19M | -1.50M | -2.05M |
| Capital Expenditure | -15.30K | -- | 12.40K | -146.10K | -146.10K |
| Sale of Property, Plant, and Equipment | 2.50K | 2.50K | 13.30K | 13.30K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -12.80K | 2.50K | 25.70K | -132.80K | -146.10K |
| Total Debt Issued | 2.00M | 15.00K | 65.00K | 65.00K | 65.00K |
| Total Debt Repaid | -170.40K | -183.10K | -187.60K | -172.90K | -36.50K |
| Issuance of Common Stock | 5.02M | 5.02M | 5.03M | 2.27M | 1.89M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -435.80K | -275.70K | -268.80K | -146.00K | -160.70K |
| Cash from Financing | 4.53M | 3.20M | 3.24M | 1.47M | 1.30M |
| Foreign Exchange rate Adjustments | 4.90K | 900.00 | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | -- | -- |
| Net Change in Cash | 1.54M | 799.90K | 1.08M | -159.20K | -893.10K |